Skip to main content
Signal8

Aditxt, Inc. (ADTX)

Aditxt, Inc. is a biotechnology firm dedicated to advancing immune system health through innovative mapping and reprogramming techniques. The company's developments include AditxtScore, a platform designed to empower individuals by providing insights into their immune profiles for better management and informed awareness of immune system attacks or dysfunctions. Aditxt also pioneers Apoptotic DNA Immunotherapy, a nucleic acid-based solution that emulates the body's inherent mechanisms for developing self-tolerance to its own tissues. Additionally, Aditxt is actively researching and developing ADi products with diverse therapeutic applications, such as for organ transplant procedures (including skin grafting), various autoimmune conditions, and allergic reactions. The company holds licensing agreements with esteemed institutions like Loma Linda University and Leland Stanford Junior University. Established in 2017, this Richmond, Virginia-headquartered company was initially known as ADiTx Therapeutics, Inc. before rebranding to Aditxt, Inc. in July 2021.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Aditxt, Inc. logo

Aditxt, Inc.

OTC:ADTXOTC (delisted from Nasdaq, Form 25 effective Oct 17, 2026)Healthcare
$0.0002
Mkt Cap$200K
EV-
Float997.98M
O/S997.98M
VOL52K sh
$ Vol$10
RVOL0.05×
Inst Own0.0%
Net Cash/Sh-
Dilution

Aditxt, Inc. (ADTX) dilution facts from SEC filings

Snapshot as of Mar 31, 2026, built from 67 SEC filings.

Shelf registration
S-3 filed Apr 13, 2026, effective Apr 21, 2026
Source: 424B3 filed Apr 23, 2026
At-the-market (ATM) program
Yes, sales agreement dated Dec 20, 2022
Source: 10-Q filed May 20, 2026
Warrants outstanding
6 warrant series recorded as outstanding
Most recent offering
PIPE, closed Jun 22, 2026
Source: 8-K filed Jun 23, 2026

Check another stock for dilution

Facts as recorded in the company's SEC filings. The full snapshot, with instrument terms, share counts and history, is part of Signal8 Pro.

Unlock with Signal8 Pro